FDA OKs first new ADHD drug in over a decade for children

Researchers discover a novel cell-to-cell communication network that helps tumors regrow following treatment
5 April 2021
Personalized patient navigation service reduces readmissions among hospitalized patients with comorbid substance use
6 April 2021

FDA OKs first new ADHD drug in over a decade for children

U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity.

Comments are closed.